PDS Biotechnology Corp - Common (PDSB)

CUSIP: 70465T107

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common
Shares outstanding
49,594,356
Total 13F shares
7,451,352
Share change
-789,100
Total reported value
$9,901,943
Put/Call ratio
0%
Price per share
$1.33
Number of holders
55
Value change
-$1,043,791
Number of buys
25
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 70465T107?
CUSIP 70465T107 identifies PDSB - PDS Biotechnology Corp - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q2 2025

As of 30 Jun 2025, PDS Biotechnology Corp - Common (PDSB) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,451,352 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, UBS Group AG, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, BLAIR WILLIAM & CO/IL, CITADEL ADVISORS LLC, STATE STREET CORP, NORTHERN TRUST CORP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 55 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.